Procter & Gamble Health Limited
NSE: PGHL BSE: PGHL
NSE
5,303.00
-48.50 (-0.91%)
Prev Close
5351.5
Open Price
5307.5
Volume
4,739
Today Low / High
5257.5 / 5363
52 WK Low / High
4903.85 / 6739
Range
5,038 - 5,568
BSE
5,315.70
15.60 (0.29%)
Prev Close
5300.1
Open Price
5300.2
Volume
235
Today Low / High
5281 / 5357.5
52 WK Low / High
4916 / 6700
Range
5,050 - 5,581
The stock is currently trading on both the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE). On the NSE, the stock is priced at 5303 (target range: 5,038 - 5,568), reflecting a change of -48.5 (-0.90629%). On the BSE, it is listed at 5315.7 (target range: 5,050 - 5,581), showing a change of 15.6 (0.29433%). The stock price is currently in decline on both exchanges, signaling a downtrend. If you're considering investing in this stock, it's important to monitor the situation closely.
01 Feb
5,346.50
-0.81%
30 Jan
5,346.50
-0.81%
29 Jan
5,380.50
-0.54%
28 Jan
5,410.50
-0.55%
27 Jan
5,355.00
0.93%
23 Jan
5,400.50
-0.09%
22 Jan
5,411.00
-0.12%
21 Jan
5,430.50
-0.36%
20 Jan
5,443.00
0.14%
19 Jan
5,445.00
-0.04%
16 Jan
5,374.50
1.24%
14 Jan
5,392.00
-0.20%
13 Jan
5,499.00
-2.05%
12 Jan
5,580.00
-2.22%
09 Jan
5,691.50
-1.98%
08 Jan
5,677.50
0.40%
07 Jan
5,740.50
-0.60%
06 Jan
5,840.00
-1.70%
05 Jan
5,701.50
2.50%
Procter & Gamble Health Limited Graph
Procter & Gamble Health Limited Price Target Predictions: Bullish vs. Bearish Scenarios with Ranges
If you are looking for the target price for Procter & Gamble Health Limited T1, T2, T3 for both Bullish and Bearish scenarios, here it is. For Bullish: T1, T2, T3. For Bearish: T1, T2, T3. The stock current price is 5,303.00, with potential price targets ranging from T1, T2, and T3 in both directions based on market conditions.
| Scenario | Price | Target | Range |
|---|---|---|---|
| Bullish Scenario | 5,315.70 | 5,368.86 | 4,831.97 - 5,905.74 |
| 5,422.01 | 4,337.61 - 6,506.42 | ||
| 5,475.17 | 3,832.62 - 7,117.72 | ||
| Bearish Scenario | 5,315.70 | 5,262.54 | 4,736.29 - 5,788.80 |
| 5,209.39 | 4,167.51 - 6,251.26 | ||
| 5,156.23 | 3,609.36 - 6,703.10 |
Overview of Procter & Gamble Health Limited
ISIN
INE199A01012
Industry
Drug Manufacturers - Specialty & Generic
Vol.Avg
7,554
Market Cap
88,026,522,746
Last Dividend
125
Official Website
IPO Date
2002-07-01
DCF Diff
-10,769.71
DCF
16,165
Financial Ratios Every Investor Needs
Stock Dividend of PGHL
| Date | Label | Adj Dividend | Dividend | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|---|
| 2025-08-22 | August 22, 25 | 45 | 45 | 2025-08-22 | 2025-09-25 | |
| 2025-02-21 | February 21, 25 | 80 | 80 | 2025-02-21 | 2025-03-07 | |
| 2024-11-28 | November 28, 24 | 60 | 60 | 2024-11-28 | 2024-12-25 | |
| 2024-02-14 | February 14, 24 | 200 | 200 | 2024-02-14 | 2024-03-03 | |
| 2023-11-23 | November 23, 23 | 50 | 50 | 2023-11-23 | 2023-12-30 |
Annual Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | R&D Expenses | G&A Expenses | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 1,218.05 Cr | 348.97 Cr | 869.08 Cr | 0.7135 | 2.61 Cr | 190.97 Cr | 633.17 Cr | 251.19 Cr | 151.33 | 362.09 Cr | 0.2062 |
| 2024-03-31 | 1,151.26 Cr | 342.54 Cr | 808.72 Cr | 0.7025 | 3.86 Cr | 215.53 Cr | 536.68 Cr | 200.98 Cr | 121.08 | 303.41 Cr | 0.1746 |
| 2023-03-31 | 1,229.62 Cr | 383.37 Cr | 846.25 Cr | 0.6882 | 5.71 Cr | 206.64 Cr | 559.41 Cr | 229.47 Cr | 138.24 | 318.75 Cr | 0.1866 |
| 2022-03-31 | 1,114.41 Cr | 353.05 Cr | 761.36 Cr | 0.6832 | 6.55 Cr | 168.19 Cr | 477.17 Cr | 192.52 Cr | 115.98 | 264.77 Cr | 0.1728 |
| 2021-03-31 | 1,008.73 Cr | 324.51 Cr | 684.22 Cr | 0.6783 | 3.93 Cr | 155.19 Cr | 437.69 Cr | 176.80 Cr | 106.51 | 242.40 Cr | 0.1753 |
Annual Financials Balance Sheet
| Date | C&C Equ. | Tot. Assets | Tot. Liab. | Stock. Equity | Tot. Debt | Net Debt | Inv. | PP&E (Net) | Curr. Def. Rev. | Non-Curr. Def. Rev. | LT Invest. | Curr. Liab. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 188.55 Cr | 794.20 Cr | 257.24 Cr | 536.9600 Cr | 7.62 Cr | -180.93 Cr | 109.37 Cr | 121.99 Cr | 0.00 Cr | 0.00 Cr | 19.33 Cr | 215.3100 Cr |
| 2024-06-30 | 244.36 Cr | 794.36 Cr | 256.12 Cr | 538.2400 Cr | 9.56 Cr | -234.80 Cr | 109.11 Cr | 131.53 Cr | 0.00 Cr | 0.00 Cr | 11.64 Cr | 218.9100 Cr |
| 2023-06-30 | 435.05 Cr | 1,101.19 Cr | 350.30 Cr | 750.8900 Cr | 12.00 Cr | -423.05 Cr | 134.94 Cr | 173.27 Cr | 54.82 Cr | 0.00 Cr | -12.64 Cr | 303.9000 Cr |
| 2022-06-30 | 319.40 Cr | 893.72 Cr | 277.23 Cr | 616.4900 Cr | 2.83 Cr | -316.57 Cr | 115.21 Cr | 149.62 Cr | 0.56 Cr | 0.00 Cr | -3.83 Cr | 235.8300 Cr |
| 2021-06-30 | 464.05 Cr | 986.16 Cr | 282.45 Cr | 703.7100 Cr | 7.61 Cr | -456.44 Cr | 118.37 Cr | 140.13 Cr | 97.22 Cr | 0.00 Cr | -2.66 Cr | 238.9700 Cr |
Annual Financials Cash Flow Statement
| Date | Operating Cash | Investing Cash | Financing Cash | Free Cash | Cash Change | Cash at End | CapEx | Income | Debt Repay | Dividends | Inventory |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-03-31 | 175.8400 Cr | 2.4400 Cr | -234.7400 Cr | 167.2800 Cr | -251.6700 Cr | 188.5500 Cr | -8.5600 Cr | 312.5459 Cr | 0.0000 Cr | -232.4000 Cr | -2.3700 Cr |
| 2024-06-30 | 228.2800 Cr | -6.8700 Cr | -418.1100 Cr | 206.5600 Cr | -196.6900 Cr | 238.7300 Cr | -21.7300 Cr | 200.9800 Cr | 0.0000 Cr | -414.9900 Cr | 23.1300 Cr |
| 2023-06-30 | 236.0000 Cr | -21.5000 Cr | -98.4700 Cr | 193.5200 Cr | 116.0200 Cr | 435.4200 Cr | -42.4800 Cr | 314.2000 Cr | 0.0000 Cr | -93.7900 Cr | -32.3900 Cr |
| 2022-06-30 | 169.5200 Cr | -25.5400 Cr | -288.6300 Cr | 131.6000 Cr | -144.6500 Cr | 319.4000 Cr | -37.9200 Cr | 253.3700 Cr | 0.0000 Cr | -283.8500 Cr | -2.0200 Cr |
| 2021-06-30 | 247.2600 Cr | -32.2700 Cr | -386.6300 Cr | 194.6800 Cr | -171.6400 Cr | 464.0500 Cr | -52.5800 Cr | 233.2800 Cr | 0.0000 Cr | -381.7800 Cr | 15.2600 Cr |
Quarterly Financial Income Report
| Date | Revenue | Co.Rev | GP | GPR | Operating Income | Net Income | EPS | EBITDA | NIR |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 324.92 Cr | 128.36 Cr | 196.56 Cr | 0.6049 | 114.19 Cr | 88.54 Cr | 53.34 | 125.22 Cr | 0.2725 |
| 2025-06-30 | 338.74 Cr | 93.99 Cr | 244.75 Cr | 0.7225 | 188.74 Cr | 66.18 Cr | 39.87 | 90.34 Cr | 0.1954 |
| 2025-03-31 | 310.99 Cr | 98.72 Cr | 212.27 Cr | 0.6826 | 163.48 Cr | 61.18 Cr | 36.86 | 80.92 Cr | 0.1967 |
| 2024-12-31 | 309.77 Cr | 75.73 Cr | 234.04 Cr | 0.7555 | 186.99 Cr | 90.90 Cr | 54.76 | 123.54 Cr | 0.2934 |
| 2024-09-30 | 338.74 Cr | 93.99 Cr | 244.75 Cr | 0.7225 | 188.74 Cr | 66.18 Cr | 39.87 | 90.34 Cr | 0.1954 |
Quarterly Financials Balance Sheet
| Date | Cash & Equiv. | Short-Term Inv. | Cash & Short-Term | Net Receivables | Inventory | Total Curr. Assets | PP&E (Net) | Total Assets | Total Liabilities |
|---|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 286.17 Cr | 0.00 Cr | 286.17 Cr | 139.18 Cr | 127.33 Cr | 639.26 Cr | 114.24 Cr | 894.40 Cr | 274.67 Cr |
| 2025-06-30 | 0.00 Cr | 0.00 Cr | 188.55 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -536.96 Cr |
| 2025-03-31 | 182.08 Cr | 23.98 Cr | 206.06 Cr | 146.99 Cr | 109.37 Cr | 526.39 Cr | 121.99 Cr | 794.20 Cr | 257.24 Cr |
| 2024-12-31 | 266.43 Cr | 25.83 Cr | 292.26 Cr | 132.24 Cr | 118.78 Cr | 612.49 Cr | 125.27 Cr | 870.15 Cr | 259.69 Cr |
| 2024-09-30 | 0.00 Cr | 0.00 Cr | 244.36 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | -538.24 Cr |
Quarterly Financials Cash Flow Statement
| Date | Net Income | Operating Cash Flow | Investing Cash Flow | Financing Cash Flow | Net Cash Change | Cash at End | Cash at Beginning | CapEx | Free Cash Flow |
|---|---|---|---|---|---|---|---|---|---|
| 2025-06-30 | 66.18 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2025-03-31 | 78.53 Cr | 49.22 Cr | -0.05 Cr | -133.58 Cr | -84.41 Cr | 182.27 Cr | 266.68 Cr | -3.23 Cr | 45.99 Cr |
| 2024-12-31 | 90.90 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-09-30 | 82.33 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
| 2024-06-30 | 16.78 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr | 0.00 Cr |
Splits History
| Date | Label | Split Ratio |
|---|---|---|
| No split history data available. | ||
Similar Stocks: Drug Manufacturers - Specialty & Generic
| Company Name | Symbol | Price | Market Cap | Volume |
|---|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA | ₹1,595.30 | ₹3,827,659,077,641.00 | ₹1,849,710.00 |
| Divi's Laboratories Limited | DIVISLAB | ₹6,031.00 | ₹1,601,041,005,980.00 | ₹96,030.00 |
| Torrent Pharmaceuticals Limited | TORNTPHARM | ₹3,960.80 | ₹1,340,514,698,752.00 | ₹50,076.00 |
| Dr. Reddy's Laboratories Limited | DRREDDY | ₹1,200.00 | ₹999,081,828,000.00 | ₹380,220.00 |
| Lupin Limited | LUPIN | ₹2,152.80 | ₹983,396,887,200.00 | ₹153,290.00 |
| Zydus Lifesciences Limited | ZYDUSLIFE | ₹885.30 | ₹890,818,951,347.00 | ₹140,316.00 |
| Mankind Pharma Limited | MANKIND | ₹2,124.00 | ₹876,797,972,928.00 | ₹287,261.00 |
| Aurobindo Pharma Limited | AUROPHARMA | ₹1,182.80 | ₹686,972,159,684.00 | ₹574,635.00 |
| Alkem Laboratories Limited | ALKEM | ₹5,620.00 | ₹671,955,300,000.00 | ₹20,830.00 |
| Glenmark Pharmaceuticals Limited | GLENMARK | ₹1,960.90 | ₹553,367,566,368.00 | ₹308,665.00 |
| Laurus Labs Limited | LAURUSLABS | ₹940.90 | ₹507,951,058,004.00 | ₹1,196,464.00 |
| Suven Pharmaceuticals Limited | SUVENPHAR | ₹1,078.00 | ₹412,407,234,624.00 | ₹1,177,218.00 |
| Ipca Laboratories Limited | IPCALAB | ₹1,427.70 | ₹362,213,512,039.00 | ₹38,416.00 |
| Ajanta Pharma Limited | AJANTPHARM | ₹2,782.00 | ₹347,570,905,968.00 | ₹27,274.00 |
| J. B. Chemicals & Pharmaceuticals Limited | JBCHEPHARM | ₹1,880.70 | ₹301,730,104,500.00 | ₹48,837.00 |
| Emcure Pharmaceuticals Ltd. | EMCURE | ₹1,485.00 | ₹281,515,221,900.00 | ₹56,011.00 |
| Piramal Enterprises Limited | PEL | ₹1,124.20 | ₹254,856,250,172.00 | ₹2,148,582.00 |
| Wockhardt Limited | WOCKPHARMA | ₹1,382.20 | ₹224,596,675,992.00 | ₹241,327.00 |
| AstraZeneca Pharma India Limited | ASTRAZEN | ₹8,615.00 | ₹215,375,000,000.00 | ₹3,296.00 |
| Eris Lifesciences Limited | ERIS | ₹1,386.10 | ₹188,810,232,615.00 | ₹11,485.00 |
| Neuland Laboratories Limited | NEULANDLAB | ₹13,251.00 | ₹170,008,859,139.00 | ₹53,893.00 |
| Alembic Pharmaceuticals Limited | APLLTD | ₹777.60 | ₹152,847,485,222.00 | ₹26,375.00 |
| Jubilant Pharmova Limited | JUBLPHARMA | ₹953.75 | ₹151,045,147,155.00 | ₹22,670.00 |
| NATCO Pharma Limited | NATCOPHARM | ₹835.90 | ₹149,717,940,333.00 | ₹208,764.00 |
| Cohance Lifesciences Limited | COHANCE | ₹367.50 | ₹140,593,423,950.00 | ₹169,039.00 |
| Caplin Point Laboratories Limited | CAPLIPOINT | ₹1,802.10 | ₹136,980,677,362.00 | ₹25,851.00 |
| Granules India Limited | GRANULES | ₹557.20 | ₹135,215,008,555.00 | ₹273,857.00 |
| Glenmark Life Sciences Limited | GLS | ₹1,086.00 | ₹133,070,838,000.00 | ₹130,938.00 |
| Alivus Life Sciences Ltd. | ALIVUS | ₹937.60 | ₹115,025,705,600.00 | ₹28,984.00 |
| Viyash Scientific Limited | VIYASH | ₹203.61 | ₹88,815,813,868.00 | ₹245,657.00 |
| Procter & Gamble Health Limited | PGHL | ₹5,303.00 | ₹88,026,522,746.00 | ₹4,739.00 |
| Strides Pharma Science Limited | STAR | ₹877.00 | ₹80,835,470,178.00 | ₹379,638.00 |
| Aarti Pharmalabs Limited | AARTIPHARM | ₹756.05 | ₹68,533,886,629.00 | ₹69,500.00 |
| Akums Drugs & Pharmaceuticals Ltd. | AKUMS | ₹446.00 | ₹68,283,517,868.00 | ₹92,422.00 |
| FDC Limited | FDC | ₹376.70 | ₹61,330,558,643.00 | ₹31,298.00 |
| Shilpa Medicare Limited | SHILPAMED | ₹288.95 | ₹56,513,365,733.00 | ₹4,776,413.00 |
| Sequent Scientific Limited | SEQUENT | ₹202.40 | ₹50,564,340,966.00 | ₹13,647.00 |
| Sun Pharma Advanced Research Company Limited | SPARC | ₹126.08 | ₹40,915,681,815.00 | ₹7,990,855.00 |
| Innova Captab Limited | INNOVACAP | ₹695.00 | ₹39,771,325,655.00 | ₹12,945.00 |
| Gujarat Themis Biosyn Ltd. | GUJTHEM | ₹326.85 | ₹35,615,296,865.00 | ₹58,760.00 |
| Aarti Drugs Limited | AARTIDRUGS | ₹386.75 | ₹35,298,672,500.00 | ₹63,468.00 |
| Orchid Pharma Limited | ORCHPHARMA | ₹693.00 | ₹35,148,339,765.00 | ₹14,366.00 |
| RPG Life Sciences Limited | RPGLIFE | ₹2,007.90 | ₹33,208,688,219.00 | ₹3,827.00 |
| Gufic Biosciences Limited | GUFICBIO | ₹303.90 | ₹30,475,853,573.00 | ₹29,080.00 |
| Suven Life Sciences Limited | SUVEN | ₹132.81 | ₹30,210,821,940.00 | ₹346,948.00 |
Key Executives
MD & Executive Director
Milind Vasant Thatte
Gender: male
Year Born: 1969
CFO & Executive Director
Shashank Srowthy
Gender: male
Year Born:
Director of Sales, Distributor Operations & Sales Stewardship Leader
Vishal Naik
Gender: male
Year Born:
Assistant Company Secretary
Prachi Vichare
Gender: female
Year Born:
Human Resource Leader
Sanika Gokhale
Gender: female
Year Born:
Compliance Officer & Company Secretary
Zeal Bhavin Rupani
Gender: female
Year Born:
FAQs about Procter & Gamble Health Limited
Who is the CEO of the company?
The CEO is Milind Vasant Thatte.
What is the current market price of the stock?
The current price is ₹5,303.00.
What is the 52-week price range?
The range is ₹4903.85-6739.
What is the market capitalization of the company?
The market capitalization is ₹8,802.65 crores.
What is the dividend yield?
The dividend yield is 2.36%.
What is the Price-to-Earnings (P/E) ratio?
The P/E ratio is 28.69.
Which sector does the company belong to?
The company operates in the Healthcare sector.
What does the company do?
Overview of Procter & Gamble Health Limited (ISIN: INE199A01012) is a leading Drug Manufacturers - Specialty & Generic in India. With a market capitalization of ₹8,802.65 crores and an average daily volume of 7,554 shares, it operates in the Drug Manufacturers - Specialty & Generic. The company last declared a dividend of ₹125.